ACUR: Analyst Opinion for Acura Pharmaceuticals, Inc. - Yahoo! Finance

MORE ON ACUR

Quotes

Historical Prices

Charts

Basic Tech. Analysis

News & Info

Financial Blogs

Company

Analyst Coverage

Analyst Opinion

Analyst Estimates

Research Reports

Ownership

Insider Transactions

Financials

Income Statement

Analyst Opinion	Get Analyst Opinion for:

RECOMMENDATION SUMMARY*

Mean Recommendation (this week):	1
Mean Recommendation (last week):	1
Change:	0.0

* (Strong Buy) 1.0 - 5.0 (Sell)

Compare to Industry

PRICE TARGET SUMMARY

Mean Target:	8.00
Median Target:	8.00
High Target:	8.00
Low Target:	8.00
No. of Brokers:	1

Data provided by Thomson/First Call

UPGRADES & DOWNGRADES HISTORY

No Upgrades & Downgrades available for ACUR

RECOMMENDATION TRENDS

	Current Month	Last Month	Two Months Ago	Three Months Ago
Strong Buy	0	0	0	0
Buy	0	0	0	0
Hold	0	0	0	0
Underperform	0	0	0	0
Sell	0	0	0	0

Data provided by Thomson/First Call

Add to Portfolio

Set Alert

Email to a Friend

•

Upgrades & Downgrades

•

Conference Calls

Copyright © 2006 Yahoo! Inc. All rights reserved. Terms of Service.
To learn more about Yahoo!'s use of personal information, please read the Privacy Policy.

Quotes delayed, except where indicated otherwise.
Delay times are 15 mins for NASDAQ, 20 mins for NYSE and Amex. See also delay times for other exchanges.

Fundamental company data provided by Capital IQ. Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page. Quotes are updated automatically, but will be turned off after 25 minutes of inactivity. Quotes are delayed at least 15 minutes. Real-Time continuous streaming quotes are available through our premium service. You may turn streaming quotes on or off. Analyst opinion data (recommendation summary, price targets, coverage list) are provided by Thomson Financial Network, based solely upon research information provided by third party analysts. Yahoo! has not reviewed, and in no way endorses the validity of such data. Yahoo! and ThomsonFN shall not be liable for any actions taken in reliance thereon. Analyst Summary Information (upgrades/downgrades module) provided by Briefing.com. All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.